nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—UGT1A1—Indacaterol—asthma	0.261	0.52	CbGbCtD
Naltrexone—ABCB1—Fluticasone furoate—asthma	0.0634	0.126	CbGbCtD
Naltrexone—ABCB1—Indacaterol—asthma	0.0517	0.103	CbGbCtD
Naltrexone—ABCB1—Loratadine—asthma	0.0276	0.055	CbGbCtD
Naltrexone—ABCB1—Methylprednisolone—asthma	0.0252	0.0503	CbGbCtD
Naltrexone—ABCB1—Betamethasone—asthma	0.0164	0.0327	CbGbCtD
Naltrexone—ABCB1—Prednisolone—asthma	0.0162	0.0323	CbGbCtD
Naltrexone—ABCB1—Hydrocortisone—asthma	0.0153	0.0306	CbGbCtD
Naltrexone—ABCB1—Prednisone—asthma	0.0153	0.0305	CbGbCtD
Naltrexone—ABCB1—Dexamethasone—asthma	0.00954	0.019	CbGbCtD
Naltrexone—Naloxone—TLR4—asthma	0.00207	0.889	CrCbGaD
Naltrexone—Naloxone—ALB—asthma	0.000259	0.111	CrCbGaD
Naltrexone—Hallucination—Prednisone—asthma	5.11e-05	0.000145	CcSEcCtD
Naltrexone—Malaise—Triamcinolone—asthma	5.1e-05	0.000144	CcSEcCtD
Naltrexone—Anxiety—Hydrocortisone—asthma	5.1e-05	0.000144	CcSEcCtD
Naltrexone—Malaise—Methylprednisolone—asthma	5.09e-05	0.000144	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	5.08e-05	0.000144	CcSEcCtD
Naltrexone—Syncope—Triamcinolone—asthma	5.08e-05	0.000144	CcSEcCtD
Naltrexone—Syncope—Methylprednisolone—asthma	5.06e-05	0.000143	CcSEcCtD
Naltrexone—Discomfort—Hydrocortisone—asthma	5.06e-05	0.000143	CcSEcCtD
Naltrexone—Connective tissue disorder—Prednisone—asthma	5.05e-05	0.000143	CcSEcCtD
Naltrexone—Nausea—Budesonide—asthma	5.04e-05	0.000143	CcSEcCtD
Naltrexone—Oedema—Prednisolone—asthma	5.02e-05	0.000142	CcSEcCtD
Naltrexone—Anaphylactic shock—Prednisolone—asthma	5.02e-05	0.000142	CcSEcCtD
Naltrexone—Loss of consciousness—Triamcinolone—asthma	4.97e-05	0.000141	CcSEcCtD
Naltrexone—Loss of consciousness—Methylprednisolone—asthma	4.96e-05	0.00014	CcSEcCtD
Naltrexone—Shock—Prednisolone—asthma	4.94e-05	0.00014	CcSEcCtD
Naltrexone—Cough—Triamcinolone—asthma	4.94e-05	0.00014	CcSEcCtD
Naltrexone—Oedema—Hydrocortisone—asthma	4.91e-05	0.000139	CcSEcCtD
Naltrexone—Anaphylactic shock—Hydrocortisone—asthma	4.91e-05	0.000139	CcSEcCtD
Naltrexone—Convulsion—Triamcinolone—asthma	4.9e-05	0.000139	CcSEcCtD
Naltrexone—Tachycardia—Prednisolone—asthma	4.9e-05	0.000139	CcSEcCtD
Naltrexone—Convulsion—Methylprednisolone—asthma	4.89e-05	0.000138	CcSEcCtD
Naltrexone—Hypertension—Triamcinolone—asthma	4.89e-05	0.000138	CcSEcCtD
Naltrexone—Hypertension—Methylprednisolone—asthma	4.88e-05	0.000138	CcSEcCtD
Naltrexone—Infection—Hydrocortisone—asthma	4.87e-05	0.000138	CcSEcCtD
Naltrexone—Hyperhidrosis—Prednisolone—asthma	4.86e-05	0.000137	CcSEcCtD
Naltrexone—Shock—Hydrocortisone—asthma	4.83e-05	0.000137	CcSEcCtD
Naltrexone—Myalgia—Triamcinolone—asthma	4.82e-05	0.000136	CcSEcCtD
Naltrexone—Nervous system disorder—Hydrocortisone—asthma	4.81e-05	0.000136	CcSEcCtD
Naltrexone—Arthralgia—Methylprednisolone—asthma	4.81e-05	0.000136	CcSEcCtD
Naltrexone—Myalgia—Methylprednisolone—asthma	4.81e-05	0.000136	CcSEcCtD
Naltrexone—Eye disorder—Prednisone—asthma	4.8e-05	0.000136	CcSEcCtD
Naltrexone—Anxiety—Methylprednisolone—asthma	4.79e-05	0.000136	CcSEcCtD
Naltrexone—Tachycardia—Hydrocortisone—asthma	4.79e-05	0.000135	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	4.77e-05	0.000135	CcSEcCtD
Naltrexone—Skin disorder—Hydrocortisone—asthma	4.76e-05	0.000135	CcSEcCtD
Naltrexone—Ill-defined disorder—Dexamethasone—asthma	4.76e-05	0.000135	CcSEcCtD
Naltrexone—Ill-defined disorder—Betamethasone—asthma	4.76e-05	0.000135	CcSEcCtD
Naltrexone—Discomfort—Triamcinolone—asthma	4.76e-05	0.000135	CcSEcCtD
Naltrexone—Discomfort—Methylprednisolone—asthma	4.75e-05	0.000134	CcSEcCtD
Naltrexone—Hyperhidrosis—Hydrocortisone—asthma	4.74e-05	0.000134	CcSEcCtD
Naltrexone—Dry mouth—Triamcinolone—asthma	4.71e-05	0.000133	CcSEcCtD
Naltrexone—Angioedema—Betamethasone—asthma	4.69e-05	0.000133	CcSEcCtD
Naltrexone—Angioedema—Dexamethasone—asthma	4.69e-05	0.000133	CcSEcCtD
Naltrexone—Anorexia—Hydrocortisone—asthma	4.68e-05	0.000132	CcSEcCtD
Naltrexone—Angiopathy—Prednisone—asthma	4.66e-05	0.000132	CcSEcCtD
Naltrexone—Confusional state—Methylprednisolone—asthma	4.65e-05	0.000131	CcSEcCtD
Naltrexone—Immune system disorder—Prednisone—asthma	4.64e-05	0.000131	CcSEcCtD
Naltrexone—Malaise—Dexamethasone—asthma	4.63e-05	0.000131	CcSEcCtD
Naltrexone—Malaise—Betamethasone—asthma	4.63e-05	0.000131	CcSEcCtD
Naltrexone—Anaphylactic shock—Triamcinolone—asthma	4.62e-05	0.000131	CcSEcCtD
Naltrexone—Oedema—Triamcinolone—asthma	4.62e-05	0.000131	CcSEcCtD
Naltrexone—Anaphylactic shock—Methylprednisolone—asthma	4.61e-05	0.00013	CcSEcCtD
Naltrexone—Syncope—Betamethasone—asthma	4.61e-05	0.00013	CcSEcCtD
Naltrexone—Syncope—Dexamethasone—asthma	4.61e-05	0.00013	CcSEcCtD
Naltrexone—Infection—Triamcinolone—asthma	4.59e-05	0.00013	CcSEcCtD
Naltrexone—Infection—Methylprednisolone—asthma	4.58e-05	0.00013	CcSEcCtD
Naltrexone—Shock—Triamcinolone—asthma	4.54e-05	0.000129	CcSEcCtD
Naltrexone—Insomnia—Prednisolone—asthma	4.54e-05	0.000129	CcSEcCtD
Naltrexone—Alopecia—Prednisone—asthma	4.54e-05	0.000128	CcSEcCtD
Naltrexone—Shock—Methylprednisolone—asthma	4.53e-05	0.000128	CcSEcCtD
Naltrexone—Nervous system disorder—Methylprednisolone—asthma	4.52e-05	0.000128	CcSEcCtD
Naltrexone—Loss of consciousness—Betamethasone—asthma	4.51e-05	0.000128	CcSEcCtD
Naltrexone—Loss of consciousness—Dexamethasone—asthma	4.51e-05	0.000128	CcSEcCtD
Naltrexone—Paraesthesia—Prednisolone—asthma	4.51e-05	0.000128	CcSEcCtD
Naltrexone—Tachycardia—Triamcinolone—asthma	4.51e-05	0.000128	CcSEcCtD
Naltrexone—Mental disorder—Prednisone—asthma	4.5e-05	0.000127	CcSEcCtD
Naltrexone—Tachycardia—Methylprednisolone—asthma	4.5e-05	0.000127	CcSEcCtD
Naltrexone—Skin disorder—Methylprednisolone—asthma	4.48e-05	0.000127	CcSEcCtD
Naltrexone—Malnutrition—Prednisone—asthma	4.47e-05	0.000127	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Hydrocortisone—asthma	4.47e-05	0.000126	CcSEcCtD
Naltrexone—Hyperhidrosis—Triamcinolone—asthma	4.47e-05	0.000126	CcSEcCtD
Naltrexone—Hyperhidrosis—Methylprednisolone—asthma	4.46e-05	0.000126	CcSEcCtD
Naltrexone—Convulsion—Dexamethasone—asthma	4.45e-05	0.000126	CcSEcCtD
Naltrexone—Convulsion—Betamethasone—asthma	4.45e-05	0.000126	CcSEcCtD
Naltrexone—Insomnia—Hydrocortisone—asthma	4.44e-05	0.000126	CcSEcCtD
Naltrexone—Hypertension—Dexamethasone—asthma	4.43e-05	0.000125	CcSEcCtD
Naltrexone—Hypertension—Betamethasone—asthma	4.43e-05	0.000125	CcSEcCtD
Naltrexone—Paraesthesia—Hydrocortisone—asthma	4.4e-05	0.000125	CcSEcCtD
Naltrexone—Myalgia—Betamethasone—asthma	4.37e-05	0.000124	CcSEcCtD
Naltrexone—Myalgia—Dexamethasone—asthma	4.37e-05	0.000124	CcSEcCtD
Naltrexone—Anxiety—Betamethasone—asthma	4.36e-05	0.000123	CcSEcCtD
Naltrexone—Anxiety—Dexamethasone—asthma	4.36e-05	0.000123	CcSEcCtD
Naltrexone—Discomfort—Dexamethasone—asthma	4.32e-05	0.000122	CcSEcCtD
Naltrexone—Discomfort—Betamethasone—asthma	4.32e-05	0.000122	CcSEcCtD
Naltrexone—Pain—Prednisolone—asthma	4.3e-05	0.000122	CcSEcCtD
Naltrexone—Decreased appetite—Hydrocortisone—asthma	4.26e-05	0.000121	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Hydrocortisone—asthma	4.24e-05	0.00012	CcSEcCtD
Naltrexone—Fatigue—Hydrocortisone—asthma	4.23e-05	0.00012	CcSEcCtD
Naltrexone—Vision blurred—Prednisone—asthma	4.21e-05	0.000119	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Triamcinolone—asthma	4.21e-05	0.000119	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Methylprednisolone—asthma	4.2e-05	0.000119	CcSEcCtD
Naltrexone—Pain—Hydrocortisone—asthma	4.19e-05	0.000119	CcSEcCtD
Naltrexone—Oedema—Dexamethasone—asthma	4.19e-05	0.000119	CcSEcCtD
Naltrexone—Oedema—Betamethasone—asthma	4.19e-05	0.000119	CcSEcCtD
Naltrexone—Anaphylactic shock—Dexamethasone—asthma	4.19e-05	0.000119	CcSEcCtD
Naltrexone—Anaphylactic shock—Betamethasone—asthma	4.19e-05	0.000119	CcSEcCtD
Naltrexone—Insomnia—Triamcinolone—asthma	4.18e-05	0.000118	CcSEcCtD
Naltrexone—Insomnia—Methylprednisolone—asthma	4.17e-05	0.000118	CcSEcCtD
Naltrexone—Infection—Betamethasone—asthma	4.16e-05	0.000118	CcSEcCtD
Naltrexone—Infection—Dexamethasone—asthma	4.16e-05	0.000118	CcSEcCtD
Naltrexone—Ill-defined disorder—Prednisone—asthma	4.15e-05	0.000117	CcSEcCtD
Naltrexone—Paraesthesia—Triamcinolone—asthma	4.15e-05	0.000117	CcSEcCtD
Naltrexone—Feeling abnormal—Prednisolone—asthma	4.14e-05	0.000117	CcSEcCtD
Naltrexone—Paraesthesia—Methylprednisolone—asthma	4.14e-05	0.000117	CcSEcCtD
Naltrexone—Shock—Dexamethasone—asthma	4.12e-05	0.000117	CcSEcCtD
Naltrexone—Shock—Betamethasone—asthma	4.12e-05	0.000117	CcSEcCtD
Naltrexone—Dyspnoea—Triamcinolone—asthma	4.12e-05	0.000117	CcSEcCtD
Naltrexone—Nervous system disorder—Betamethasone—asthma	4.11e-05	0.000116	CcSEcCtD
Naltrexone—Nervous system disorder—Dexamethasone—asthma	4.11e-05	0.000116	CcSEcCtD
Naltrexone—Agitation—Prednisone—asthma	4.11e-05	0.000116	CcSEcCtD
Naltrexone—Tachycardia—Dexamethasone—asthma	4.09e-05	0.000116	CcSEcCtD
Naltrexone—Tachycardia—Betamethasone—asthma	4.09e-05	0.000116	CcSEcCtD
Naltrexone—Angioedema—Prednisone—asthma	4.09e-05	0.000116	CcSEcCtD
Naltrexone—Hyperhidrosis—Dexamethasone—asthma	4.05e-05	0.000115	CcSEcCtD
Naltrexone—Hyperhidrosis—Betamethasone—asthma	4.05e-05	0.000115	CcSEcCtD
Naltrexone—Feeling abnormal—Hydrocortisone—asthma	4.04e-05	0.000114	CcSEcCtD
Naltrexone—Malaise—Prednisone—asthma	4.03e-05	0.000114	CcSEcCtD
Naltrexone—Gastrointestinal pain—Hydrocortisone—asthma	4.01e-05	0.000114	CcSEcCtD
Naltrexone—Syncope—Prednisone—asthma	4.01e-05	0.000113	CcSEcCtD
Naltrexone—Anorexia—Dexamethasone—asthma	4e-05	0.000113	CcSEcCtD
Naltrexone—Anorexia—Betamethasone—asthma	4e-05	0.000113	CcSEcCtD
Naltrexone—Urticaria—Prednisolone—asthma	3.99e-05	0.000113	CcSEcCtD
Naltrexone—Fatigue—Triamcinolone—asthma	3.98e-05	0.000113	CcSEcCtD
Naltrexone—Fatigue—Methylprednisolone—asthma	3.97e-05	0.000112	CcSEcCtD
Naltrexone—Pain—Triamcinolone—asthma	3.95e-05	0.000112	CcSEcCtD
Naltrexone—Loss of consciousness—Prednisone—asthma	3.93e-05	0.000111	CcSEcCtD
Naltrexone—Urticaria—Hydrocortisone—asthma	3.9e-05	0.00011	CcSEcCtD
Naltrexone—Abdominal pain—Hydrocortisone—asthma	3.88e-05	0.00011	CcSEcCtD
Naltrexone—Body temperature increased—Hydrocortisone—asthma	3.88e-05	0.00011	CcSEcCtD
Naltrexone—Convulsion—Prednisone—asthma	3.87e-05	0.00011	CcSEcCtD
Naltrexone—Hypertension—Prednisone—asthma	3.86e-05	0.000109	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Dexamethasone—asthma	3.82e-05	0.000108	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Betamethasone—asthma	3.82e-05	0.000108	CcSEcCtD
Naltrexone—Arthralgia—Prednisone—asthma	3.81e-05	0.000108	CcSEcCtD
Naltrexone—Myalgia—Prednisone—asthma	3.81e-05	0.000108	CcSEcCtD
Naltrexone—Feeling abnormal—Triamcinolone—asthma	3.81e-05	0.000108	CcSEcCtD
Naltrexone—Feeling abnormal—Methylprednisolone—asthma	3.8e-05	0.000107	CcSEcCtD
Naltrexone—Anxiety—Prednisone—asthma	3.79e-05	0.000107	CcSEcCtD
Naltrexone—Insomnia—Dexamethasone—asthma	3.79e-05	0.000107	CcSEcCtD
Naltrexone—Insomnia—Betamethasone—asthma	3.79e-05	0.000107	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	3.78e-05	0.000107	CcSEcCtD
Naltrexone—Gastrointestinal pain—Methylprednisolone—asthma	3.77e-05	0.000107	CcSEcCtD
Naltrexone—Paraesthesia—Betamethasone—asthma	3.76e-05	0.000106	CcSEcCtD
Naltrexone—Paraesthesia—Dexamethasone—asthma	3.76e-05	0.000106	CcSEcCtD
Naltrexone—Discomfort—Prednisone—asthma	3.76e-05	0.000106	CcSEcCtD
Naltrexone—Hypersensitivity—Prednisolone—asthma	3.7e-05	0.000105	CcSEcCtD
Naltrexone—Urticaria—Triamcinolone—asthma	3.67e-05	0.000104	CcSEcCtD
Naltrexone—Urticaria—Methylprednisolone—asthma	3.66e-05	0.000104	CcSEcCtD
Naltrexone—Body temperature increased—Triamcinolone—asthma	3.65e-05	0.000103	CcSEcCtD
Naltrexone—Oedema—Prednisone—asthma	3.65e-05	0.000103	CcSEcCtD
Naltrexone—Anaphylactic shock—Prednisone—asthma	3.65e-05	0.000103	CcSEcCtD
Naltrexone—Abdominal pain—Methylprednisolone—asthma	3.64e-05	0.000103	CcSEcCtD
Naltrexone—Decreased appetite—Dexamethasone—asthma	3.64e-05	0.000103	CcSEcCtD
Naltrexone—Decreased appetite—Betamethasone—asthma	3.64e-05	0.000103	CcSEcCtD
Naltrexone—Infection—Prednisone—asthma	3.63e-05	0.000103	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Betamethasone—asthma	3.62e-05	0.000102	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Dexamethasone—asthma	3.62e-05	0.000102	CcSEcCtD
Naltrexone—Hypersensitivity—Hydrocortisone—asthma	3.61e-05	0.000102	CcSEcCtD
Naltrexone—Fatigue—Dexamethasone—asthma	3.61e-05	0.000102	CcSEcCtD
Naltrexone—Fatigue—Betamethasone—asthma	3.61e-05	0.000102	CcSEcCtD
Naltrexone—Shock—Prednisone—asthma	3.59e-05	0.000102	CcSEcCtD
Naltrexone—Pain—Dexamethasone—asthma	3.58e-05	0.000101	CcSEcCtD
Naltrexone—Pain—Betamethasone—asthma	3.58e-05	0.000101	CcSEcCtD
Naltrexone—Nervous system disorder—Prednisone—asthma	3.58e-05	0.000101	CcSEcCtD
Naltrexone—Tachycardia—Prednisone—asthma	3.56e-05	0.000101	CcSEcCtD
Naltrexone—Skin disorder—Prednisone—asthma	3.55e-05	0.0001	CcSEcCtD
Naltrexone—Hyperhidrosis—Prednisone—asthma	3.53e-05	9.98e-05	CcSEcCtD
Naltrexone—Asthenia—Hydrocortisone—asthma	3.52e-05	9.96e-05	CcSEcCtD
Naltrexone—Anorexia—Prednisone—asthma	3.48e-05	9.85e-05	CcSEcCtD
Naltrexone—Pruritus—Hydrocortisone—asthma	3.47e-05	9.82e-05	CcSEcCtD
Naltrexone—Feeling abnormal—Dexamethasone—asthma	3.45e-05	9.77e-05	CcSEcCtD
Naltrexone—Feeling abnormal—Betamethasone—asthma	3.45e-05	9.77e-05	CcSEcCtD
Naltrexone—Gastrointestinal pain—Dexamethasone—asthma	3.43e-05	9.7e-05	CcSEcCtD
Naltrexone—Gastrointestinal pain—Betamethasone—asthma	3.43e-05	9.7e-05	CcSEcCtD
Naltrexone—Hypersensitivity—Triamcinolone—asthma	3.4e-05	9.63e-05	CcSEcCtD
Naltrexone—Hypersensitivity—Methylprednisolone—asthma	3.4e-05	9.61e-05	CcSEcCtD
Naltrexone—Diarrhoea—Hydrocortisone—asthma	3.36e-05	9.5e-05	CcSEcCtD
Naltrexone—Urticaria—Dexamethasone—asthma	3.33e-05	9.42e-05	CcSEcCtD
Naltrexone—Urticaria—Betamethasone—asthma	3.33e-05	9.42e-05	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Prednisone—asthma	3.33e-05	9.41e-05	CcSEcCtD
Naltrexone—Dizziness—Prednisolone—asthma	3.32e-05	9.4e-05	CcSEcCtD
Naltrexone—Asthenia—Triamcinolone—asthma	3.31e-05	9.38e-05	CcSEcCtD
Naltrexone—Abdominal pain—Dexamethasone—asthma	3.31e-05	9.38e-05	CcSEcCtD
Naltrexone—Body temperature increased—Dexamethasone—asthma	3.31e-05	9.38e-05	CcSEcCtD
Naltrexone—Body temperature increased—Betamethasone—asthma	3.31e-05	9.38e-05	CcSEcCtD
Naltrexone—Abdominal pain—Betamethasone—asthma	3.31e-05	9.38e-05	CcSEcCtD
Naltrexone—Asthenia—Methylprednisolone—asthma	3.31e-05	9.36e-05	CcSEcCtD
Naltrexone—Insomnia—Prednisone—asthma	3.3e-05	9.34e-05	CcSEcCtD
Naltrexone—Paraesthesia—Prednisone—asthma	3.28e-05	9.27e-05	CcSEcCtD
Naltrexone—Pruritus—Triamcinolone—asthma	3.27e-05	9.25e-05	CcSEcCtD
Naltrexone—Pruritus—Methylprednisolone—asthma	3.26e-05	9.23e-05	CcSEcCtD
Naltrexone—Dizziness—Hydrocortisone—asthma	3.24e-05	9.18e-05	CcSEcCtD
Naltrexone—Decreased appetite—Prednisone—asthma	3.17e-05	8.98e-05	CcSEcCtD
Naltrexone—OPRK1—GPCR downstream signaling—C3—asthma	3.17e-05	0.000222	CbGpPWpGaD
Naltrexone—Rash—Prednisolone—asthma	3.17e-05	8.96e-05	CcSEcCtD
Naltrexone—OPRD1—Signaling Pathways—CXCR3—asthma	3.17e-05	0.000221	CbGpPWpGaD
Naltrexone—Dermatitis—Prednisolone—asthma	3.16e-05	8.95e-05	CcSEcCtD
Naltrexone—OPRM1—Signaling Pathways—CCR4—asthma	3.16e-05	0.000221	CbGpPWpGaD
Naltrexone—Diarrhoea—Methylprednisolone—asthma	3.15e-05	8.92e-05	CcSEcCtD
Naltrexone—Fatigue—Prednisone—asthma	3.15e-05	8.9e-05	CcSEcCtD
Naltrexone—Headache—Prednisolone—asthma	3.15e-05	8.9e-05	CcSEcCtD
Naltrexone—UGT1A1—Metabolism—GSTT1—asthma	3.12e-05	0.000218	CbGpPWpGaD
Naltrexone—Constipation—Prednisone—asthma	3.12e-05	8.83e-05	CcSEcCtD
Naltrexone—Vomiting—Hydrocortisone—asthma	3.12e-05	8.83e-05	CcSEcCtD
Naltrexone—OPRM1—Signaling by GPCR—ADRB2—asthma	3.12e-05	0.000218	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—STAT6—asthma	3.1e-05	0.000216	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NPY—asthma	3.1e-05	0.000216	CbGpPWpGaD
Naltrexone—Rash—Hydrocortisone—asthma	3.09e-05	8.75e-05	CcSEcCtD
Naltrexone—Dermatitis—Hydrocortisone—asthma	3.09e-05	8.74e-05	CcSEcCtD
Naltrexone—ABCB1—Metabolism—LTA4H—asthma	3.08e-05	0.000216	CbGpPWpGaD
Naltrexone—Headache—Hydrocortisone—asthma	3.07e-05	8.7e-05	CcSEcCtD
Naltrexone—OPRM1—GPCR downstream signaling—EDN1—asthma	3.07e-05	0.000214	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CYBA—asthma	3.07e-05	0.000214	CbGpPWpGaD
Naltrexone—Dizziness—Triamcinolone—asthma	3.05e-05	8.64e-05	CcSEcCtD
Naltrexone—Dizziness—Methylprednisolone—asthma	3.05e-05	8.62e-05	CcSEcCtD
Naltrexone—OPRM1—GPCR downstream signaling—CCL5—asthma	3.04e-05	0.000213	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL2RB—asthma	3.04e-05	0.000212	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PDE4D—asthma	3.01e-05	0.000211	CbGpPWpGaD
Naltrexone—Feeling abnormal—Prednisone—asthma	3.01e-05	8.51e-05	CcSEcCtD
Naltrexone—Asthenia—Dexamethasone—asthma	3.01e-05	8.51e-05	CcSEcCtD
Naltrexone—Asthenia—Betamethasone—asthma	3.01e-05	8.51e-05	CcSEcCtD
Naltrexone—OPRD1—Signaling Pathways—PARP1—asthma	3e-05	0.00021	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL5—asthma	3e-05	0.00021	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—PPP2CA—asthma	3e-05	0.00021	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CSF2—asthma	3e-05	0.00021	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—AGTR2—asthma	2.99e-05	0.000209	CbGpPWpGaD
Naltrexone—Gastrointestinal pain—Prednisone—asthma	2.98e-05	8.45e-05	CcSEcCtD
Naltrexone—Nausea—Prednisolone—asthma	2.98e-05	8.44e-05	CcSEcCtD
Naltrexone—Pruritus—Betamethasone—asthma	2.97e-05	8.39e-05	CcSEcCtD
Naltrexone—Pruritus—Dexamethasone—asthma	2.97e-05	8.39e-05	CcSEcCtD
Naltrexone—OPRM1—Signaling by GPCR—ITPR1—asthma	2.95e-05	0.000206	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CCR5—asthma	2.95e-05	0.000206	CbGpPWpGaD
Naltrexone—Vomiting—Triamcinolone—asthma	2.94e-05	8.31e-05	CcSEcCtD
Naltrexone—OPRM1—Signaling Pathways—PDE4B—asthma	2.94e-05	0.000205	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—C5—asthma	2.94e-05	0.000205	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TACR1—asthma	2.94e-05	0.000205	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—CXCL8—asthma	2.93e-05	0.000205	CbGpPWpGaD
Naltrexone—Vomiting—Methylprednisolone—asthma	2.93e-05	8.29e-05	CcSEcCtD
Naltrexone—Nausea—Hydrocortisone—asthma	2.91e-05	8.25e-05	CcSEcCtD
Naltrexone—Rash—Triamcinolone—asthma	2.91e-05	8.24e-05	CcSEcCtD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—asthma	2.91e-05	0.000204	CbGpPWpGaD
Naltrexone—Dermatitis—Triamcinolone—asthma	2.91e-05	8.23e-05	CcSEcCtD
Naltrexone—Rash—Methylprednisolone—asthma	2.91e-05	8.22e-05	CcSEcCtD
Naltrexone—OPRK1—Signaling by GPCR—IL2RA—asthma	2.9e-05	0.000203	CbGpPWpGaD
Naltrexone—Dermatitis—Methylprednisolone—asthma	2.9e-05	8.22e-05	CcSEcCtD
Naltrexone—Urticaria—Prednisone—asthma	2.9e-05	8.2e-05	CcSEcCtD
Naltrexone—OPRD1—Signaling Pathways—BDKRB2—asthma	2.9e-05	0.000202	CbGpPWpGaD
Naltrexone—Headache—Triamcinolone—asthma	2.89e-05	8.19e-05	CcSEcCtD
Naltrexone—OPRD1—GPCR downstream signaling—POMC—asthma	2.89e-05	0.000202	CbGpPWpGaD
Naltrexone—Headache—Methylprednisolone—asthma	2.89e-05	8.17e-05	CcSEcCtD
Naltrexone—Body temperature increased—Prednisone—asthma	2.89e-05	8.16e-05	CcSEcCtD
Naltrexone—Abdominal pain—Prednisone—asthma	2.89e-05	8.16e-05	CcSEcCtD
Naltrexone—OPRK1—Signaling by GPCR—C3—asthma	2.88e-05	0.000201	CbGpPWpGaD
Naltrexone—Diarrhoea—Betamethasone—asthma	2.87e-05	8.11e-05	CcSEcCtD
Naltrexone—Diarrhoea—Dexamethasone—asthma	2.87e-05	8.11e-05	CcSEcCtD
Naltrexone—OPRK1—Signaling Pathways—EDNRB—asthma	2.86e-05	0.0002	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NPS—asthma	2.83e-05	0.000198	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TAC1—asthma	2.83e-05	0.000198	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—ADCY2—asthma	2.8e-05	0.000196	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL3—asthma	2.79e-05	0.000195	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—EDN1—asthma	2.79e-05	0.000195	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CXCR3—asthma	2.78e-05	0.000194	CbGpPWpGaD
Naltrexone—Dizziness—Betamethasone—asthma	2.77e-05	7.84e-05	CcSEcCtD
Naltrexone—Dizziness—Dexamethasone—asthma	2.77e-05	7.84e-05	CcSEcCtD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—asthma	2.77e-05	0.000193	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CCL5—asthma	2.76e-05	0.000193	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—PLA2G4A—asthma	2.75e-05	0.000193	CbGpPWpGaD
Naltrexone—Nausea—Triamcinolone—asthma	2.74e-05	7.76e-05	CcSEcCtD
Naltrexone—OPRM1—GPCR downstream signaling—CCR5—asthma	2.74e-05	0.000192	CbGpPWpGaD
Naltrexone—Nausea—Methylprednisolone—asthma	2.74e-05	7.75e-05	CcSEcCtD
Naltrexone—OPRM1—Signaling by GPCR—CSF2—asthma	2.72e-05	0.00019	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—IL2RA—asthma	2.7e-05	0.000189	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ARG1—asthma	2.7e-05	0.000188	CbGpPWpGaD
Naltrexone—Hypersensitivity—Prednisone—asthma	2.69e-05	7.61e-05	CcSEcCtD
Naltrexone—OPRK1—Signaling Pathways—CYBA—asthma	2.69e-05	0.000188	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCR3—asthma	2.68e-05	0.000188	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—C3—asthma	2.68e-05	0.000187	CbGpPWpGaD
Naltrexone—Vomiting—Dexamethasone—asthma	2.66e-05	7.54e-05	CcSEcCtD
Naltrexone—Vomiting—Betamethasone—asthma	2.66e-05	7.54e-05	CcSEcCtD
Naltrexone—Rash—Betamethasone—asthma	2.64e-05	7.48e-05	CcSEcCtD
Naltrexone—Rash—Dexamethasone—asthma	2.64e-05	7.48e-05	CcSEcCtD
Naltrexone—Dermatitis—Dexamethasone—asthma	2.64e-05	7.47e-05	CcSEcCtD
Naltrexone—Dermatitis—Betamethasone—asthma	2.64e-05	7.47e-05	CcSEcCtD
Naltrexone—OPRD1—Signaling Pathways—KNG1—asthma	2.63e-05	0.000184	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PARP1—asthma	2.63e-05	0.000184	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL5—asthma	2.63e-05	0.000184	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—POMC—asthma	2.63e-05	0.000184	CbGpPWpGaD
Naltrexone—Headache—Dexamethasone—asthma	2.63e-05	7.43e-05	CcSEcCtD
Naltrexone—Headache—Betamethasone—asthma	2.63e-05	7.43e-05	CcSEcCtD
Naltrexone—OPRD1—Signaling Pathways—AGTR1—asthma	2.62e-05	0.000183	CbGpPWpGaD
Naltrexone—Asthenia—Prednisone—asthma	2.62e-05	7.41e-05	CcSEcCtD
Naltrexone—OPRM1—Signaling Pathways—NPY—asthma	2.62e-05	0.000183	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—NQO1—asthma	2.6e-05	0.000181	CbGpPWpGaD
Naltrexone—Pruritus—Prednisone—asthma	2.58e-05	7.31e-05	CcSEcCtD
Naltrexone—OPRD1—Signaling by GPCR—CCL2—asthma	2.57e-05	0.00018	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—IL6R—asthma	2.56e-05	0.000179	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CXCL10—asthma	2.56e-05	0.000179	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—RHOA—asthma	2.55e-05	0.000178	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ADCY2—asthma	2.54e-05	0.000178	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—BDKRB2—asthma	2.54e-05	0.000178	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—PPP2CA—asthma	2.54e-05	0.000177	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—POMC—asthma	2.54e-05	0.000177	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—AGTR2—asthma	2.52e-05	0.000176	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—NTRK1—asthma	2.51e-05	0.000176	CbGpPWpGaD
Naltrexone—Diarrhoea—Prednisone—asthma	2.5e-05	7.07e-05	CcSEcCtD
Naltrexone—OPRM1—Signaling by GPCR—CCR5—asthma	2.49e-05	0.000174	CbGpPWpGaD
Naltrexone—Nausea—Dexamethasone—asthma	2.49e-05	7.04e-05	CcSEcCtD
Naltrexone—Nausea—Betamethasone—asthma	2.49e-05	7.04e-05	CcSEcCtD
Naltrexone—ABCB1—Transmembrane transport of small molecules—ADCY2—asthma	2.49e-05	0.000174	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—ADRB2—asthma	2.48e-05	0.000174	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—ADCY2—asthma	2.46e-05	0.000172	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL2RA—asthma	2.45e-05	0.000172	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL3—asthma	2.45e-05	0.000171	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ALDH7A1—asthma	2.44e-05	0.00017	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—C3—asthma	2.43e-05	0.00017	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—EDNRB—asthma	2.42e-05	0.000169	CbGpPWpGaD
Naltrexone—Dizziness—Prednisone—asthma	2.41e-05	6.83e-05	CcSEcCtD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—asthma	2.41e-05	0.000169	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TAC1—asthma	2.39e-05	0.000167	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NPS—asthma	2.39e-05	0.000167	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—ITPR1—asthma	2.35e-05	0.000164	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CXCR3—asthma	2.35e-05	0.000164	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ARG2—asthma	2.34e-05	0.000163	CbGpPWpGaD
Naltrexone—Vomiting—Prednisone—asthma	2.32e-05	6.57e-05	CcSEcCtD
Naltrexone—OPRD1—Signaling by GPCR—RHOA—asthma	2.31e-05	0.000162	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—KNG1—asthma	2.31e-05	0.000162	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—POMC—asthma	2.3e-05	0.000161	CbGpPWpGaD
Naltrexone—Rash—Prednisone—asthma	2.3e-05	6.51e-05	CcSEcCtD
Naltrexone—Dermatitis—Prednisone—asthma	2.3e-05	6.51e-05	CcSEcCtD
Naltrexone—OPRK1—Signaling Pathways—AGTR1—asthma	2.3e-05	0.000161	CbGpPWpGaD
Naltrexone—Headache—Prednisone—asthma	2.29e-05	6.47e-05	CcSEcCtD
Naltrexone—OPRM1—Signaling Pathways—CYBA—asthma	2.27e-05	0.000159	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CCL2—asthma	2.25e-05	0.000158	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—IL6R—asthma	2.25e-05	0.000157	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CXCL10—asthma	2.24e-05	0.000157	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CD86—asthma	2.24e-05	0.000156	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—CXCL8—asthma	2.24e-05	0.000156	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—RHOA—asthma	2.23e-05	0.000156	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PARP1—asthma	2.22e-05	0.000156	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL5—asthma	2.22e-05	0.000156	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—EDN1—asthma	2.22e-05	0.000155	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CCL5—asthma	2.2e-05	0.000154	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NTRK1—asthma	2.2e-05	0.000154	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PLA2G4A—asthma	2.19e-05	0.000153	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	2.18e-05	0.000152	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—ADRB2—asthma	2.18e-05	0.000152	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CSF2—asthma	2.17e-05	0.000152	CbGpPWpGaD
Naltrexone—Nausea—Prednisone—asthma	2.17e-05	6.13e-05	CcSEcCtD
Naltrexone—UGT1A1—Metabolism—GSTP1—asthma	2.16e-05	0.000151	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—BDKRB2—asthma	2.15e-05	0.00015	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—POMC—asthma	2.14e-05	0.00015	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—IL2—asthma	2.14e-05	0.000149	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—HMOX1—asthma	2.13e-05	0.000149	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ITPR1—asthma	2.13e-05	0.000149	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—SMAD3—asthma	2.11e-05	0.000148	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—CAT—asthma	2.11e-05	0.000147	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—HMOX1—asthma	2.09e-05	0.000146	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ADCY2—asthma	2.08e-05	0.000145	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL3—asthma	2.07e-05	0.000145	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—ITPR1—asthma	2.06e-05	0.000144	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CXCL8—asthma	2.03e-05	0.000142	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—RHOA—asthma	2.03e-05	0.000142	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PPP2CA—asthma	2.02e-05	0.000141	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	2e-05	0.00014	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PLA2G4A—asthma	1.99e-05	0.000139	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—GSTM1—asthma	1.99e-05	0.000139	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CCR5—asthma	1.98e-05	0.000139	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CD86—asthma	1.96e-05	0.000137	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CXCL8—asthma	1.96e-05	0.000137	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—asthma	1.96e-05	0.000137	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL2RA—asthma	1.96e-05	0.000137	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—KNG1—asthma	1.95e-05	0.000137	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—EDN1—asthma	1.95e-05	0.000136	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—POMC—asthma	1.95e-05	0.000136	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—IL2—asthma	1.94e-05	0.000136	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—AGTR1—asthma	1.94e-05	0.000136	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—C3—asthma	1.94e-05	0.000136	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ALOX5AP—asthma	1.94e-05	0.000135	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ALOX15—asthma	1.94e-05	0.000135	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCL5—asthma	1.93e-05	0.000135	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PLA2G4A—asthma	1.92e-05	0.000135	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CCL2—asthma	1.9e-05	0.000133	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CSF2—asthma	1.9e-05	0.000133	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL6R—asthma	1.9e-05	0.000133	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CXCL10—asthma	1.9e-05	0.000133	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—RHOA—asthma	1.89e-05	0.000132	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PDGFB—asthma	1.89e-05	0.000132	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—IL2—asthma	1.87e-05	0.000131	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—asthma	1.87e-05	0.000131	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NTRK1—asthma	1.86e-05	0.00013	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—SMAD3—asthma	1.85e-05	0.00013	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CHAT—asthma	1.85e-05	0.000129	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ADRB2—asthma	1.84e-05	0.000129	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PPP2CA—asthma	1.83e-05	0.000128	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—LEP—asthma	1.81e-05	0.000126	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CXCL8—asthma	1.78e-05	0.000125	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PPP2CA—asthma	1.77e-05	0.000124	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ITPR1—asthma	1.74e-05	0.000122	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCR5—asthma	1.74e-05	0.000122	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL2RA—asthma	1.72e-05	0.00012	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—RHOA—asthma	1.71e-05	0.00012	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—FN1—asthma	1.7e-05	0.000119	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—IL2—asthma	1.7e-05	0.000119	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—C3—asthma	1.7e-05	0.000119	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CD86—asthma	1.66e-05	0.000116	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CXCL8—asthma	1.66e-05	0.000116	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PDGFB—asthma	1.66e-05	0.000116	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ALOX5—asthma	1.65e-05	0.000115	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—EDN1—asthma	1.65e-05	0.000115	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCL5—asthma	1.63e-05	0.000114	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PLA2G4A—asthma	1.63e-05	0.000114	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CSF2—asthma	1.61e-05	0.000112	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—IL2—asthma	1.58e-05	0.000111	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—LEP—asthma	1.58e-05	0.000111	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CARM1—asthma	1.57e-05	0.00011	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—SMAD3—asthma	1.57e-05	0.000109	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—POMC—asthma	1.55e-05	0.000108	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—DCN—asthma	1.55e-05	0.000108	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CCL2—asthma	1.52e-05	0.000106	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL6R—asthma	1.51e-05	0.000106	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ALDH2—asthma	1.51e-05	0.000105	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CXCL8—asthma	1.51e-05	0.000105	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PPP2CA—asthma	1.5e-05	0.000105	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—FN1—asthma	1.49e-05	0.000104	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—EGFR—asthma	1.48e-05	0.000104	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCR5—asthma	1.47e-05	0.000103	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL2RA—asthma	1.45e-05	0.000101	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL2—asthma	1.44e-05	0.000101	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—C3—asthma	1.44e-05	0.000101	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GSTT1—asthma	1.43e-05	0.0001	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—SERPINE1—asthma	1.42e-05	9.91e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—POMC—asthma	1.41e-05	9.83e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PDGFB—asthma	1.4e-05	9.78e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—RHOA—asthma	1.37e-05	9.56e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—POMC—asthma	1.36e-05	9.51e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—NOS3—asthma	1.35e-05	9.46e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—LEP—asthma	1.34e-05	9.36e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCL2—asthma	1.33e-05	9.31e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL6R—asthma	1.33e-05	9.28e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—EGFR—asthma	1.3e-05	9.1e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ALB—asthma	1.28e-05	8.96e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—FN1—asthma	1.26e-05	8.82e-05	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—ALB—asthma	1.26e-05	8.78e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—SERPINE1—asthma	1.24e-05	8.69e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—NOS3—asthma	1.23e-05	8.57e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CXCL8—asthma	1.2e-05	8.39e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—RHOA—asthma	1.2e-05	8.38e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—NQO1—asthma	1.19e-05	8.32e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NOS3—asthma	1.19e-05	8.29e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ADCY2—asthma	1.17e-05	8.15e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—POMC—asthma	1.15e-05	8.04e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL2—asthma	1.15e-05	8.02e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—IL6—asthma	1.14e-05	7.98e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCL2—asthma	1.12e-05	7.86e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL6R—asthma	1.12e-05	7.84e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PTGS2—asthma	1.12e-05	7.84e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—EGFR—asthma	1.1e-05	7.69e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—MMP9—asthma	1.09e-05	7.59e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PTEN—asthma	1.08e-05	7.54e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CXCL8—asthma	1.05e-05	7.36e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—SERPINE1—asthma	1.05e-05	7.34e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—RHOA—asthma	1.01e-05	7.08e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL2—asthma	1.01e-05	7.03e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NOS3—asthma	1e-05	7.01e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—IL6—asthma	1e-05	7e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GSTP1—asthma	9.93e-06	6.94e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—HMOX1—asthma	9.79e-06	6.85e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PTEN—asthma	9.78e-06	6.84e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ITPR1—asthma	9.77e-06	6.83e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—VEGFA—asthma	9.75e-06	6.81e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CAT—asthma	9.66e-06	6.76e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—STAT3—asthma	9.65e-06	6.75e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—MMP9—asthma	9.52e-06	6.65e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PTEN—asthma	9.46e-06	6.62e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PLA2G4A—asthma	9.13e-06	6.38e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GSTM1—asthma	9.13e-06	6.38e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TGFB1—asthma	8.95e-06	6.25e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CXCL8—asthma	8.89e-06	6.22e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—EGFR—asthma	8.77e-06	6.13e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—VEGFA—asthma	8.55e-06	5.98e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL2—asthma	8.5e-06	5.94e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—STAT3—asthma	8.46e-06	5.92e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL6—asthma	8.46e-06	5.91e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PPP2CA—asthma	8.4e-06	5.88e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—MMP9—asthma	8.04e-06	5.62e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PTEN—asthma	8e-06	5.59e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TGFB1—asthma	7.84e-06	5.48e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—EGFR—asthma	7.69e-06	5.38e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—VEGFA—asthma	7.22e-06	5.05e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—STAT3—asthma	7.15e-06	5e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL6—asthma	6.74e-06	4.71e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TGFB1—asthma	6.63e-06	4.64e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—EGFR—asthma	6.5e-06	4.54e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—POMC—asthma	6.45e-06	4.51e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL6—asthma	5.91e-06	4.13e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ALB—asthma	5.88e-06	4.11e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—NOS3—asthma	5.62e-06	3.93e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PTGS2—asthma	5.14e-06	3.6e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL6—asthma	5e-06	3.49e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PTEN—asthma	4.49e-06	3.14e-05	CbGpPWpGaD
